Medicinal products with active substance USTEKINUMAB II.
Léčivé přípravky s účinnou látkou USTEKINUMAB II.
Czechia · Brno · how to bid here →
Your path to submission
- Deadline: 12 October at 00:00 — 30 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: CES, CES.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- 195% of the bids received came from small and medium-sized enterprises (441 procedures with a bid mix). Sector: 95%.n = 441
- 19% of this buyer's awards went to companies that had already won here before (2,660 awards since 2015, spread over 224 companies). That is well below the sector norm (69%) — this buyer switches suppliers more often than others.n = 2,660 awards since 2015
- In this sector the buyer awards roughly every 12 months (538 awards, most recently July 2026) — the next award is due around July 2027 by that rhythm. The last award went to ROCHE s.r.o..n = 538
- The median procedure drew just one bid (2,235 procedures with a bid count); 61% ended with a single bidder. Sector: median 2 bids.n = 2,235
- The award came in at a median 100% of the estimated value (51 awards with both estimate and value) — pricing at the estimate is usually about right here. Sector: 98%.n = 51
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 10/09/2026.
Foreign bidders
In Czechia · Medical equipment & pharma, 100 contracts went to foreign companies over the last 3 years (of 16,560 recorded awards) — mostly from Germany, Poland, Austria.
Typical field: median 1 (from 333 awards).
What the buyer is looking for
Předmětem zadávacího řízení je uzavření rámcové kupní smlouvy na dodávky léčivých přípravků dle potřeb zadavatele.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in CES, CES.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | 89 | 2022–2026 |
| Alliance Healthcare s.r.o. | 68 | 2015–2026 |
| PROMEDICA PRAHA GROUP, a.s. | 40 | 2019–2026 |
| ROCHE s.r.o. | 24 | 2015–2026 |
| PHARMOS, a.s. | 21 | 2022–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.